Immunoglobulin G2 Antibody as a Potential Target for COVID-19 Vaccine

The global threat of COVID-19 is continued with no commercially available vaccine or drug yet. While the application of convalescent therapy is usually beneficial, for critically ill patients, the detrimental effect associated with some antibodies is also reported. The immunoglobulin G (IgG) antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Andualem, Henok, Kiros, Mulugeta, Getu, Sisay, Hailemichael, Wasihun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532904/
https://www.ncbi.nlm.nih.gov/pubmed/33062618
http://dx.doi.org/10.2147/ITT.S274746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532904/
https://www.ncbi.nlm.nih.gov/pubmed/33062618
http://dx.doi.org/10.2147/ITT.S274746

Ejemplares similares